Page last updated: 2024-10-31

mexiletine and Brachial Paresis

mexiletine has been researched along with Brachial Paresis in 2 studies

Mexiletine: Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.
mexiletine : An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol.

Research Excerpts

ExcerptRelevanceReference
"Patients with spinal and bulbar muscular atrophy (SBMA) often experience muscular weakness under cold exposure."3.11Mexiletine in spinal and bulbar muscular atrophy: a randomized controlled trial. ( Hashizume, A; Hijikata, Y; Hirakawa, A; Inagaki, T; Ito, D; Katsuno, M; Kinoshita, F; Kishimoto, Y; Nakamura, T; Shimizu, S; Yamada, S, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Yamada, S2
Hashizume, A2
Hijikata, Y2
Inagaki, T2
Ito, D2
Kishimoto, Y1
Kinoshita, F2
Hirakawa, A2
Shimizu, S1
Nakamura, T2
Katsuno, M2
Nakatochi, M1
Kobayashi, Y1

Trials

2 trials available for mexiletine and Brachial Paresis

ArticleYear
Mexiletine in spinal and bulbar muscular atrophy: a randomized controlled trial.
    Annals of clinical and translational neurology, 2022, Volume: 9, Issue:11

    Topics: Bulbo-Spinal Atrophy, X-Linked; Humans; Mexiletine; Muscle Weakness; Paresis; Pressure; Tongue

2022
Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS).
    BMJ open, 2018, 09-11, Volume: 8, Issue:9

    Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Bulbo-Spinal Atrophy, X-Linked; Cold Tem

2018